BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23900048)

  • 1. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
    Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung.
    Ashek A; Spruijt OA; Harms HJ; Lammertsma AA; Cupitt J; Dubois O; Wharton J; Dabral S; Pullamsetti SS; Huisman MC; Frings V; Boellaard R; de Man FS; Botros L; Jansen S; Vonk Noordegraaf A; Wilkins MR; Bogaard HJ; Zhao L
    Circ Cardiovasc Imaging; 2018 Aug; 11(8):e007402. PubMed ID: 30354494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension.
    Marsboom G; Wietholt C; Haney CR; Toth PT; Ryan JJ; Morrow E; Thenappan T; Bache-Wiig P; Piao L; Paul J; Chen CT; Archer SL
    Am J Respir Crit Care Med; 2012 Mar; 185(6):670-9. PubMed ID: 22246173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
    Wang L; Xiong C; Li M; Zeng X; Wang Q; Fang W; Zhao L
    Ann Nucl Med; 2020 Jun; 34(6):407-414. PubMed ID: 32314147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
    Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
    J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.
    Cotroneo E; Ashek A; Wang L; Wharton J; Dubois O; Bozorgi S; Busbridge M; Alavian KN; Wilkins MR; Zhao L
    Circ Res; 2015 May; 116(10):1680-90. PubMed ID: 25767292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension.
    Akagi S; Nakamura K; Miura D; Saito Y; Matsubara H; Ogawa A; Matoba T; Egashira K; Ito H
    Int Heart J; 2015 May; 56(3):354-9. PubMed ID: 25902888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension.
    Li W; Wang L; Xiong CM; Yang T; Zhang Y; Gu Q; Yang Y; Ni XH; Liu ZH; Fang W; He JG
    Clin Nucl Med; 2015 Nov; 40(11):859-63. PubMed ID: 26359560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
    Godinas L; Guignabert C; Seferian A; Perros F; Bergot E; Sibille Y; Humbert M; Montani D
    Semin Respir Crit Care Med; 2013 Oct; 34(5):714-24. PubMed ID: 24037637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
    Tu L; De Man FS; Girerd B; Huertas A; Chaumais MC; Lecerf F; François C; Perros F; Dorfmüller P; Fadel E; Montani D; Eddahibi S; Humbert M; Guignabert C
    Am J Respir Crit Care Med; 2012 Oct; 186(7):666-76. PubMed ID: 22798315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.
    Lundgrin EL; Park MM; Sharp J; Tang WH; Thomas JD; Asosingh K; Comhair SA; DiFilippo FP; Neumann DR; Davis L; Graham BB; Tuder RM; Dostanic I; Erzurum SC
    Ann Am Thorac Soc; 2013 Feb; 10(1):1-9. PubMed ID: 23509326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
    Malle P; Sorschag M; Gallowitsch HJ
    Wien Med Wochenschr; 2012 Oct; 162(19-20):423-9. PubMed ID: 22890522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease.
    Ohira H; deKemp R; Kadoya Y; Renaud J; Stewart DJ; Davies RA; Chandy G; Contreras-Dominguez V; Pugliese C; Dunne R; Beanlands R; Mielniczuk L
    Ann Nucl Cardiol; 2022; 8(1):21-29. PubMed ID: 36540173
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats.
    Dahal BK; Kosanovic D; Kaulen C; Cornitescu T; Savai R; Hoffmann J; Reiss I; Ghofrani HA; Weissmann N; Kuebler WM; Seeger W; Grimminger F; Schermuly RT
    Respir Res; 2011 May; 12(1):60. PubMed ID: 21535881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin.
    Dupuis J; Harel F; Fu Y; Nguyen QT; Letourneau M; Préfontaine A; Fournier A
    J Nucl Med; 2009 Jul; 50(7):1110-5. PubMed ID: 19525474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor up-regulates Ca
    Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
    FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic [18F]fluorodeoxyglucose uptake measured by positron emission tomography/computed tomography in pulmonary hypertension.
    Frille A; Steinhoff KG; Hesse S; Grachtrup S; Wald A; Wirtz H; Sabri O; Seyfarth HJ
    Medicine (Baltimore); 2016 Jun; 95(25):e3976. PubMed ID: 27336898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.
    Demetri GD; Heinrich MC; Fletcher JA; Fletcher CD; Van den Abbeele AD; Corless CL; Antonescu CR; George S; Morgan JA; Chen MH; Bello CL; Huang X; Cohen DP; Baum CM; Maki RG
    Clin Cancer Res; 2009 Sep; 15(18):5902-9. PubMed ID: 19737946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.